Novavax, Inc. (NVAX)
8.19
-0.48
(-5.54%)
USD |
NASDAQ |
Jan 14, 16:00
8.09
-0.10
(-1.22%)
After-Hours: 07:05
Novavax SG&A Expense (TTM): 201.70M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Moderna, Inc. | 1.061B |
| Merck & Co., Inc. | 10.70B |
| Arcturus Therapeutics Holdings, Inc. | 44.43M |
| Denali Therapeutics, Inc. | 127.16M |